Carrolee Barlow is Director of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 17,201 shares of SUPN, which is worth approximately $629,728. The most recent transaction as insider was on Feb 23, 2024, when has been sold 3,886 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.2K
0% 3M change
29.19% 12M change
Total Value Held $629,728

Carrolee Barlow Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 23 2024
BUY
Grant, award, or other acquisition
-
3,886 Added 18.43%
17,201 Common Stock
Feb 22 2023
BUY
Grant, award, or other acquisition
-
3,882 Added 22.57%
13,315 Common Stock
Feb 19 2022
BUY
Grant, award, or other acquisition
-
4,222 Added 30.92%
9,433 Common Stock
CB

Carrolee Barlow

Director
Rockville, MD

Track Institutional and Insider Activities on SUPN

Follow SUPERNUS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SUPN shares.

Notify only if

Insider Trading

Get notified when an Supernus Pharmaceuticals, Inc. insider buys or sells SUPN shares.

Notify only if

News

Receive news related to SUPERNUS PHARMACEUTICALS, INC.

Track Activities on SUPN